2010•Leukemia ResearchRequires access

Do we need to do fluorescence in situ hybridization analysis in myelodysplastic syndromes as often as we do?

Dolors Costa, Sandra Valera, Ana Carrió, Amparo Arias, Concha Muñoz, Marı́a Rozman, Mohamed Belkaid, Rita Coutinho, Benet Nomdedeu, Elı́as Campo

Open publisher page 32 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 32 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Fluorescence in situ hybridization, Cytogenetics, Myelodysplastic syndromes, Fish <Actinopterygii>, Biology, Molecular cytogenetics, Karyotype, Pathology

Back to paper search Browse research topics Original source

Do we need to do fluorescence in situ hybridization analysis in myelodysplastic syndromes as often as we do? — Research Paper | ScholarLens